Chickasaw Capital Management Llc increased Valero Energy Partners Lp (VLP) stake by 6.17% reported in 2018Q1 SEC filing. Chickasaw Capital Management Llc acquired 96,069 shares as Valero Energy Partners Lp (VLP)’s stock rose 1.84%. The Chickasaw Capital Management Llc holds 1.65M shares with $58.60 million value, up from 1.56 million last quarter. Valero Energy Partners Lp now has $2.87 billion valuation. The stock decreased 0.34% or $0.14 during the last trading session, reaching $40.65. About 88,479 shares traded. Valero Energy Partners LP (NYSE:VLP) has declined 11.79% since June 14, 2017 and is downtrending. It has underperformed by 24.36% the S&P500. Some Historical VLP News: ; 27/04/2018 – VALERO CORPUS CHRISTI EAST EMISSIONS EVENT REPORT; 26/04/2018 – VALERO ENERGY PARTNERS LP QTRLY NET INCOME PER LIMITED PARTNER COMMON UNIT $0.72; 19/04/2018 – Valero Energy Partners LP Increases Quarterly Cash Distribution by 3.9 Percent; 28/03/2018 – Texas Emissions: 281217 – VALERO PARTNERS PORT ARTHUR; 30/04/2018 – The combined company that would leapfrog Valero Energy as the largest U.S. refiner by capacity; 26/03/2018 – Valero Energy Partners LP Announces Pricing of Notes Offering; 19/04/2018 – VALERO TEXAS CITY REFINERY BLAST HAPPENED ON A UNIT: OFFICIAL; 19/04/2018 – VALERO TEXAS CITY TEXAS REFINERY FIRE CONTAINED -CITY EMERGENCY MANAGEMENT; 19/04/2018 – Valero Energy Partners LP Increases Qtrly Cash Distribution by 3.9 %; 26/03/2018 – S&PGR Rates Valero Energy Partners Prpsd Unsec Notes ‘BBB-‘
Geode Capital Management Llc decreased Corcept Therapeutics Inc (CORT) stake by 7.1% reported in 2018Q1 SEC filing. Geode Capital Management Llc sold 67,095 shares as Corcept Therapeutics Inc (CORT)’s stock rose 20.10%. The Geode Capital Management Llc holds 878,255 shares with $14.45 million value, down from 945,350 last quarter. Corcept Therapeutics Inc now has $2.20 billion valuation. The stock increased 1.49% or $0.28 during the last trading session, reaching $19.13. About 949,379 shares traded. Corcept Therapeutics Incorporated (NASDAQ:CORT) has risen 60.38% since June 14, 2017 and is uptrending. It has outperformed by 47.81% the S&P500. Some Historical CORT News: ; 08/05/2018 – CORCEPT THERAPEUTICS INC – REAFFIRMED 2018 REVENUE GUIDANCE OF $275 – 300 MLN; 14/05/2018 – Corcept Closes Above 50-Day Moving Average: Technicals; 09/05/2018 – Corcept Short-Interest Ratio Rises 28% to 21 Days; 08/05/2018 – CORCEPT THERAPEUTICS INC CORT.O SEES FY 2018 REVENUE $275 MLN TO $300 MLN; 15/05/2018 – Corcept Closes Above 200-Day Moving Average: Technicals; 16/05/2018 – Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress; 15/03/2018 – CORCEPT THERAPEUTICS FILES SUIT VS TEVA PHARMACEUTICALS; 15/03/2018 – CORCEPT THERAPEUTICS INC – FILED A LAWSUIT AGAINST TEVA FOR “INFRINGEMENT OF CORCEPT PATENTS” COVERING USE OF KORLYM(MIFEPRISTONE) 300 MG TABLETS; 23/04/2018 – DJ Corcept Therapeutics Incorporated, Inst Holders, 1Q 2018 (CORT); 08/05/2018 – CORCEPT THERAPEUTICS INC CORT.O FY2018 REV VIEW $290.2 MLN — THOMSON REUTERS l/B/E/S
Among 7 analysts covering Corcept Therapeutics (NASDAQ:CORT), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Corcept Therapeutics had 13 analyst reports since February 2, 2017 according to SRatingsIntel. The firm has “Buy” rating by FBR Capital given on Tuesday, June 12. The rating was downgraded by Stifel Nicolaus on Thursday, May 31 to “Hold”. Stifel Nicolaus maintained the stock with “Buy” rating in Friday, November 3 report. The rating was initiated by FBR Capital on Thursday, March 8 with “Buy”. The firm has “Buy” rating by Ladenburg Thalmann given on Thursday, February 2. The stock of Corcept Therapeutics Incorporated (NASDAQ:CORT) earned “Buy” rating by FBR Capital on Tuesday, March 20. Piper Jaffray maintained the stock with “Buy” rating in Friday, September 8 report. The rating was maintained by Piper Jaffray on Wednesday, October 11 with “Buy”. Seaport Global initiated the shares of CORT in report on Friday, April 13 with “Buy” rating. The stock of Corcept Therapeutics Incorporated (NASDAQ:CORT) has “Buy” rating given on Thursday, August 24 by Piper Jaffray.
Geode Capital Management Llc increased Century Communities Inc (NYSE:CCS) stake by 13,194 shares to 181,941 valued at $5.45 million in 2018Q1. It also upped Murphy Oil Corp (NYSE:MUR) stake by 253,485 shares and now owns 1.73 million shares. Cbs Corp (NYSE:CBS) was raised too.
Analysts await Corcept Therapeutics Incorporated (NASDAQ:CORT) to report earnings on August, 7. They expect $0.16 earnings per share, up 60.00% or $0.06 from last year’s $0.1 per share. CORT’s profit will be $18.43 million for 29.89 P/E if the $0.16 EPS becomes a reality. After $0.14 actual earnings per share reported by Corcept Therapeutics Incorporated for the previous quarter, Wall Street now forecasts 14.29% EPS growth.
Since January 8, 2018, it had 1 buying transaction, and 7 insider sales for $1.15 million activity. The insider FISHMAN ROBERT S sold 8,000 shares worth $125,323. BAKER G LEONARD JR sold $480,312 worth of Corcept Therapeutics Incorporated (NASDAQ:CORT) on Friday, May 11. Shares for $155,102 were bought by GALA RENEE D.
More notable recent Corcept Therapeutics Incorporated (NASDAQ:CORT) news were published by: Seekingalpha.com which released: “Update: Corcept Therapeutics Remains A Strong Buy” on June 01, 2018, also Seekingalpha.com with their article: “Reader Inquiry: What’s In Store For Corcept Therapeutics?” published on May 21, 2018, Seekingalpha.com published: “Premarket analyst action – healthcare” on May 31, 2018. More interesting news about Corcept Therapeutics Incorporated (NASDAQ:CORT) were released by: Nasdaq.com and their article: “Corcept Therapeutics Announces Positive Relacorilant Data at the 2018 American Society of Clinical Oncology Meeting” published on June 04, 2018 as well as Nasdaq.com‘s news article titled: “Market Trends Toward New Normal in Agios Pharmaceuticals, Corcept Therapeutics, Prestige Brand, Virtu Financial …” with publication date: May 17, 2018.
Investors sentiment decreased to 1.28 in Q1 2018. Its down 0.21, from 1.49 in 2017Q4. It dropped, as 28 investors sold CORT shares while 55 reduced holdings. 46 funds opened positions while 60 raised stakes. 84.82 million shares or 2.95% less from 87.40 million shares in 2017Q4 were reported. State Of Wisconsin Board, Wisconsin-based fund reported 92,000 shares. National Bank Of America Corporation De holds 599,857 shares or 0% of its portfolio. Robeco Institutional Asset Management Bv holds 17,624 shares or 0% of its portfolio. Birchview Capital Lp holds 0.82% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 75,500 shares. The Illinois-based Group Incorporated One Trading Lp has invested 0% in Corcept Therapeutics Incorporated (NASDAQ:CORT). 1.54M are owned by Invesco Ltd. Quantbot Tech LP stated it has 0.04% of its portfolio in Corcept Therapeutics Incorporated (NASDAQ:CORT). National Bank Of Montreal Can holds 15,965 shares. Gsa Capital Partners Llp stated it has 192,182 shares. Voya Inv Limited Liability reported 0% in Corcept Therapeutics Incorporated (NASDAQ:CORT). Federated Invsts Pa reported 12.69 million shares stake. Renaissance Technologies Lc holds 4.80 million shares or 0.09% of its portfolio. Fifth Third Financial Bank owns 33,211 shares for 0% of their portfolio. Moreover, State Of Alaska Department Of Revenue has 0.01% invested in Corcept Therapeutics Incorporated (NASDAQ:CORT) for 30,760 shares. Schwab Charles Inv Mngmt owns 490,663 shares.
More news for Valero Energy Partners LP (NYSE:VLP) were recently published by: Fool.com, which released: “This Is One Impressive Dividend Growth Stock” on June 09, 2018. Globenewswire.com‘s article titled: “Report: Exploring Fundamental Drivers Behind Schweitzer-Mauduit International, Valero Energy Partners LP, One …” and published on May 25, 2018 is yet another important article.